Read + Share
Ju T, Labib A, Does AV, Yosipovitch G, et al. Topical JAK-STAT inhibitor tofacitinib is effective in reducing non-atopic
dermatitis chronic itch: a case series. J Am Acad Dermatol 2022 Mar 9. pii: S0190-9622(22)00393.
PMID: 35278487
|
 |
|
Ju T, Labib A, Does AV, Yosipovitch G, et al. Topical JAK-STAT inhibitor tofacitinib is effective in reducing non-atopic
dermatitis chronic itch: a case series. J Am Acad Dermatol 2022 Mar 9. pii: S0190-9622(22)00393.
PMID: 35278487
|
|
|
|